J.-J. Péré

577 total citations
12 papers, 439 citations indexed

About

J.-J. Péré is a scholar working on Psychiatry and Mental health, Pharmacology and Neurology. According to data from OpenAlex, J.-J. Péré has authored 12 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 3 papers in Pharmacology and 2 papers in Neurology. Recurrent topics in J.-J. Péré's work include Cholinesterase and Neurodegenerative Diseases (3 papers), Dementia and Cognitive Impairment Research (3 papers) and Schizophrenia research and treatment (3 papers). J.-J. Péré is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (3 papers), Dementia and Cognitive Impairment Research (3 papers) and Schizophrenia research and treatment (3 papers). J.-J. Péré collaborates with scholars based in France, Switzerland and United Kingdom. J.-J. Péré's co-authors include I. Bourdeix, Sophie Auriacombe, Bruno Vellas, J.-M. Azorin, Ronen Spiegel, M. Giguère, Gary Remington, Marie Sarazin, Thierry Dantoine and H. D. Becker and has published in prestigious journals such as American Journal of Psychiatry, Neurology and Current Medical Research and Opinion.

In The Last Decade

J.-J. Péré

11 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J.-J. Péré France	8	238	164	78	67	41	12	439
SJ Edwards United Kingdom	4	373 1.6×	295 1.8×	184 2.4×	44 0.7×	69 1.7×	6	751
H. Gerbaldo Germany	10	152 0.6×	57 0.3×	146 1.9×	26 0.4×	50 1.2×	21	407
Pamela Cyrus United States	7	192 0.8×	190 1.2×	129 1.7×	30 0.4×	46 1.1×	8	386
Didier Meulien United States	14	309 1.3×	144 0.9×	95 1.2×	74 1.1×	20 0.5×	25	606
Anita Murthy United States	8	239 1.0×	125 0.8×	87 1.1×	18 0.3×	56 1.4×	11	504
R.S. Goldman United States	7	290 1.2×	123 0.8×	158 2.0×	29 0.4×	87 2.1×	20	517
Gus Alva United States	7	227 1.0×	67 0.4×	48 0.6×	44 0.7×	91 2.2×	12	424
Eva Kohegyi United States	10	444 1.9×	158 1.0×	58 0.7×	52 0.8×	21 0.5×	14	772
M Maggini Italy	7	159 0.7×	99 0.6×	108 1.4×	36 0.5×	49 1.2×	14	385
Stefanie Ganzer Germany	9	284 1.2×	53 0.3×	195 2.5×	26 0.4×	54 1.3×	9	461

Countries citing papers authored by J.-J. Péré

Since Specialization

Citations

This map shows the geographic impact of J.-J. Péré's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.-J. Péré with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.-J. Péré more than expected).

Fields of papers citing papers by J.-J. Péré

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.-J. Péré. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.-J. Péré. The network helps show where J.-J. Péré may publish in the future.

Co-authorship network of co-authors of J.-J. Péré

This figure shows the co-authorship network connecting the top 25 collaborators of J.-J. Péré. A scholar is included among the top collaborators of J.-J. Péré based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.-J. Péré. J.-J. Péré is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Carcaillon‐Bentata, Laure, et al.. (2011). Diagnosis of Alzheimer's disease patients with rapid cognitive decline in clinical practice: Interest of the Deco questionnaire. The journal of nutrition health & aging. 15(5). 361–366. 7 indexed citations

Dantoine, Thierry, Sophie Auriacombe, Marie Sarazin, et al.. (2005). Rivastigmine monotherapy and combination therapy with memantine in patients with moderately severe Alzheimer's disease who failed to benefit from previous cholinesterase inhibitor treatment. International Journal of Clinical Practice. 60(1). 110–118. 77 indexed citations

Llorca, Pierre‐Michel & J.-J. Péré. (2004). Leponex®, 10 ans après – Une revue clinique. L Encéphale. 30(5). 474–491. 12 indexed citations

André‐Grégoire, Gwennan, et al.. (2003). No additional benefit of HRT on response to rivastigmine in menopausal women with AD. Neurology. 60(1). 148–149. 30 indexed citations

Auriacombe, Sophie, et al.. (2002). Efficacy and Safety of Rivastigmine in Patients with Alzheimer's Disease who Failed to Benefit from Treatment with Donepezil. Current Medical Research and Opinion. 18(3). 129–138. 86 indexed citations

Dartigues, J.-F., et al.. (2002). [Rivastigmine in current clinical practice in patients with mild to moderate Alzheimer's disease].. PubMed. 158(8-9). 807–12. 10 indexed citations

Durif, Franck, et al.. (2001). Efficacy and Tolerability of Entacapone as Adjunctive Therapy to Levodopa in Patients with Parkinson’s Disease and End-of-Dose Deterioration in Daily Medical Practice: An Open, Multicenter Study. European Neurology. 45(2). 111–118. 37 indexed citations

Azorin, J.-M., Ronen Spiegel, Gary Remington, et al.. (2001). A Double-Blind Comparative Study of Clozapine and Risperidone in the Management of Severe Chronic Schizophrenia. American Journal of Psychiatry. 158(8). 1305–1313. 142 indexed citations

Chaumet‐Riffaud, Philippe, et al.. (1994). [Therapeutic trials in Alzheimer disease. Selection--recruitment and stratification].. PubMed. 48(3). 201–5.

10.

Péré, J.-J., et al.. (1990). [Clozapine and resistant schizophrenia].. PubMed. 16(2). 143–5. 4 indexed citations

11.

Gagnon, Marc‐André, et al.. (1988). Predictors of Non-Bedridden Survival in Dementia. European Neurology. 28(5). 270–274. 1 indexed citations

12.

Orgogozo, J.M., Rudy Capildeo, J.-J. Péré, et al.. (1983). [Development of a neurological score for the clinical evaluation of sylvian infarctions].. PubMed. 12(48). 3039–44. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact